Bone
22. Apr 2014
Decline in calcitonin receptor expression in osteocytes with age
We have previously shown that co-administration of the transient osteoclast inhibitor, salmon calcitonin (sCT), blunts the anabolic effect of parathyroid hormone (PTH) in young rats and increases osteocytic expression of the bone formation inhibitor sclerostin (Sost). To determine whether this also …
Read the publication
Journal:
Authors:
- Gooi JH,
- Chia LY,
- Walsh NC,
- Karsdal MA,
- Quinn JM,
- Martin TJ,
- Sims NA,